Insulinoma-Associated Protein 1 (INSM1)
暂无分享,去创建一个
[1] M. Lan,et al. Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics , 2019, Molecular Cancer Research.
[2] S. Mukhopadhyay,et al. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections , 2018, Modern Pathology.
[3] Y. Akagi,et al. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor , 2018, Medical Molecular Morphology.
[4] R. Lloyd,et al. Insulinoma‐associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma) , 2018, Journal of cutaneous pathology.
[5] R. Lloyd,et al. INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. , 2015, American journal of clinical pathology.
[6] Anna B. Osipovich,et al. Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3 , 2014, Development.
[7] M. Breslin,et al. INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors. , 2009, Human gene therapy.
[8] C. Birchmeier,et al. The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. , 2006, Genes & development.